Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

413

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Hypertension
Interventions
DRUG

Azilsartan medoxomil

Azilsartan medoxomil 40 mg, tablets, orally, once daily for up to 6 weeks.

DRUG

Azilsartan medoxomil

Azilsartan medoxomil 80 mg, tablets, orally, once daily for up to 6 weeks.

DRUG

Placebo

Azilsartan medoxomil placebo-matching tablets, orally, once daily for up to 6 weeks.

Trial Locations (64)

Unknown

Alabaster

Huntsville

Tempe

Freemont

Garden Grove

Long Beach

Riverside

Sacramento

San Diego

Whittier

Newark

Hialeah

Hollywood

Miami

Pembroke Pines

Atlanta

Waycross

Chicago

Avon

Elkhart

Indianapolis

Lexington

Baltimore

Ann Arbor

Bingham Farms

Southfield

Florissant

Brooklyn

Hickory

Raleigh

Salisbury

Shelby

Akron

Centerville

Cincinnati

Columbus

Willoughby Hills

Zanesville

Oklahoma City

Downingtown

Jenkintown

Anderson

Charleston

Simpsonville

Spartanburg

Dallas

Friendswood

Houston

Irving

Katy

Missouri City

North Richland Hills

Pearland

Sugarland

Riverton

Salt Lake City

Arlington

Burke

Manassas

Port Orchard

Aguas Buenas

Aibonito

Loíza

San Juan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY